Modulating Adjuvant Release Kinetics From Scaffold Vaccines to Tune Adaptive Immune Responses
Advanced Healthcare Materials · 2025-02 · 14 (5)
DOI: 10.1002/adhm.202304574 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 21.05.2024. Verfasst von Miguel C Sobral und 5 weiteren Autor:innen. Beteiligte Einrichtung: John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, 02138, USA. Hauptthemen laut MEDLINE: Adaptive Immunity, Adjuvants, Immunologic, Vaccines. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Science Foundation, National Cancer Institute.
Abstract (Originalsprache)
Increasing the potency, quality, and durability of vaccines represents a major public health challenge. A critical parameter that shapes vaccine immunity is the spatiotemporal context in which immune cells interact with antigen and adjuvant. While various material‐based strategies demonstrate that extended antigen release enhances both cellular and humoral immunity, the effect of adjuvant kinetics on vaccine‐mediated immunity remains incompletely understood. Here, a previously characterized mesoporous silica rod (MPS) biomaterial vaccine is used to develop a facile, electrostatics‐driven approach to tune in vivo kinetics of the TLR9 agonist cytosine phosphoguanosine oligodeoxynucleotide (CpG). It is demonstrated that rapid release of CpG from MPS vaccines, mediated by alterations in MPS chemistry that tune surface charge, generates potent cytotoxic T cell responses and robust, T helper type 1 (Th1)‐skewed IgG2a/c antibody titers. Immunophenotyping of lymphoid organs after MPS vaccination with slow or fast CpG release kinetics suggests that differential engagement of migratory dendritic cells and natural killer cells may contribute to the more potent responses observed with rapid adjuvant release. Taken together, these findings suggest that vaccine approaches that pair sustained release of antigen with rapid release of adjuvants with similar characteristics to CpG may drive particularly potent Th1 responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, 02138, USA.
- Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, 02215, USA.
ORCID-Profile: David J Mooney
Förderung
- NCI NIH HHS
- National Science Foundation
- National Cancer Institute
Zitieren
APA
Sobral, M. C., Cabizzosu, L., Kang, S. J., Feng, Z., Ijaz, H., & Mooney, D. J. (2025). Modulating Adjuvant Release Kinetics From Scaffold Vaccines to Tune Adaptive Immune Responses. Advanced Healthcare Materials, 14(5). https://doi.org/10.1002/adhm.202304574
Vancouver
Sobral MC, Cabizzosu L, Kang SJ, Feng Z, Ijaz H, Mooney DJ. Modulating Adjuvant Release Kinetics From Scaffold Vaccines to Tune Adaptive Immune Responses. Advanced Healthcare Materials. 2025;14(5). doi:10.1002/adhm.202304574
BibTeX
@article{Sobral2025,
author = {Sobral, Miguel C and Cabizzosu, Laura and Kang, Shawn J and Feng, Zhaoqianqi and Ijaz, Hamza and Mooney, David J},
title = {Modulating Adjuvant Release Kinetics From Scaffold Vaccines to Tune Adaptive Immune Responses},
journal = {Advanced Healthcare Materials},
year = {2025},
volume = {14},
number = {5},
doi = {10.1002/adhm.202304574}
}
EUVIMED